Jupiter Life Line Reports 15.2% FY26 Income Growth, Opens Dombivli Hospital
Jupiter Life Line Hospitals posted FY26 income of INR 1,499.8 cr (up 15.2%) with EBITDA of INR 343.3 cr (22.9% margin) and PAT of INR 194.2 cr, while Q4 revenue rose 15.1% to INR 387.8 cr. The company holds INR 545 cr cash vs INR 500 cr debt and opened its Dombivli hospital.
1. Financial Performance
Jupiter Life Line Hospitals delivered total income of INR 1,499.8 cr in FY26, up 15.2% year-on-year, with EBITDA rising 14.4% to INR 343.3 cr (22.9% margin) and full-year PAT of INR 194.2 cr. In Q4, revenue reached INR 387.8 cr (+15.1%), quarterly EBITDA was INR 89.2 cr (23% margin) and PAT was INR 50.2 cr (+11.5%).
2. Balance Sheet Position
The company maintained a healthy balance sheet with INR 545 cr of cash on hand against INR 500 cr of gross debt, remaining cash positive after significant capital expenditures. Insurance-related revenue accounted for 55.4% of total income, while bed occupancy across three established hospitals was 61.2% and overall volumes rose 9.9% to 1.08 million cases.
3. Expansion and Operational Outlook
Operational expansion is underway with the early commissioning of the 200-bed greenfield hospital in Dombivli and an addition of approximately 1,700 new beds targeting a long-term capacity of nearly 3,000 beds in Western India. Management expects insurance tie-ups for the new facility within 6–12 months, though currency depreciation and supply chain disruptions could pressure future CapEx and consumable costs.